Prellis Biologics has raised $35 million and appointed a new CEO as it seeks to advance the development of its proprietary 3D bioprinted lymph node. Raised via a Series C funding round led by Ce…
Prellis Biologics 3D bioprints lymph node to unlock antibody discovery at pace
Biotechnology firm Prellis Biologics has announced the closure of a $14.5 million Series B funding round alongside the creation of a novel antibody discovery platform. Effectively a functioning …
Prellis Biologics raises $8.7M following first animal transplant of 3D printed tissue
San Francisco biotechnology company Prellis Biologics has successfully raised $8.7 million to advance its holographic 3D bioprinting platform. A Series A investment led by specialist technology capita…